Reviewing Colgate-Palmolive (CL) & its Rivals
Colgate-Palmolive (NYSE: CL) is one of 32 public companies in the “Personal Products” industry, but how does it weigh in compared to its peers? We will compare Colgate-Palmolive to related companies based off the strength of its risk, profitability, earnings, institutional ownership, dividends, analyst recommendations and valuation.
Insider & Institutional Ownership
73.2% of Colgate-Palmolive shares are owned by institutional investors. Comparatively, 57.6% of shares of all “Personal Products” companies are owned by institutional investors. 1.0% of Colgate-Palmolive shares are owned by company insiders. Comparatively, 15.4% of shares of all “Personal Products” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Volatility and Risk
Colgate-Palmolive has a beta of 0.8, indicating that its share price is 20% less volatile than the S&P 500. Comparatively, Colgate-Palmolive’s peers have a beta of 1.09, indicating that their average share price is 9% more volatile than the S&P 500.
Valuation and Earnings
This table compares Colgate-Palmolive and its peers top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|Colgate-Palmolive||$15.18 billion||$4.42 billion||26.70|
|Colgate-Palmolive Competitors||$14.46 billion||$2.91 billion||13.98|
Colgate-Palmolive has higher revenue and earnings than its peers. Colgate-Palmolive is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently the more expensive than other companies in its industry.
Colgate-Palmolive pays an annual dividend of $1.60 per share and has a dividend yield of 2.2%. Colgate-Palmolive pays out 59.5% of its earnings in the form of a dividend. As a group, “Personal Products” companies pay a dividend yield of 2.0% and pay out 46.2% of their earnings in the form of a dividend. Colgate-Palmolive has raised its dividend for 53 consecutive years.
This is a breakdown of current recommendations for Colgate-Palmolive and its peers, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Colgate-Palmolive currently has a consensus target price of $74.80, suggesting a potential upside of 4.15%. All “Personal Products” companies have a potential downside of 1.74%. Given Colgate-Palmolive’s higher possible upside, equities analysts plainly believe Colgate-Palmolive is more favorable than its peers.
This table compares Colgate-Palmolive and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Colgate-Palmolive beats its peers on 9 of the 15 factors compared.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia. The Company’s oral care products include Colgate Total, Colgate Sensitive Pro-Relief, Colgate Max Fresh and Colgate Optic White. The Company is also engaged in various product categories of the personal care market with operations in liquid hand soap, which it sells under the Palmolive, Protex and Softsoap brands. The Company manufactures and markets a range of products for the home care market, including Palmolive and Ajax dishwashing liquids, Fabuloso and Ajax household cleaners and Murphy’s Oil Soap. The Company, through its Hill’s Pet Nutrition segment (Hill’s), manufactures pet nutrition products for dogs and cats.
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.